← Back
M 10b5-1 Plan

$ Value

$0

Shares

15,000

Price

$0

Filed

Mar 25

Insider

Name

Hagen Heidi

Title

CIK

0001585084

Roles

Director

Transaction Details

Transaction Date

2026-03-23

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. | These options, representing the right to purchase 15,000 shares, were originally granted on May 4, 2016, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company. | These options, which were awarded on May 4, 2016, would otherwise expire and become forfeitable on May 4, 2026.

Filing Info

Accession No.

0001140361-26-011091

Form Type

4

Issuer CIK

0000887359

Hagen Heidi's History

Date Ticker Type Value
2026-03-23 VCEL M $41K
2026-03-23 VCEL $486K
2026-03-23 VCEL M $0
2025-04-30 VCEL M
2025-04-30 VCEL M $0
2025-04-30 VCEL A $0
2025-04-30 VCEL A $0

Other Insiders at VCEL (90d)

Insider Bought Sold Last
MCLAUGHLIN KEVIN F $243K 2026-02-11
Colangelo Dominick
President and CEO
2026-02-24
Rubino Alan L 2026-03-25
Hagen Heidi $486K 2026-03-23
Hopper Jonathan Mark
Chief Medical Officer
$122K 2026-04-02
Halpin Michael
Chief Operating Officer
$364K 2026-03-02
Flynn Sean C.
Chief Legal Officer
$754K 2026-03-02
Mara Joseph Anthony Jr
Chief Financial Officer
2026-02-24
SIEGAL JONATHAN
Principal Accounting Officer
2026-02-24